Invesco Biotechnology & Genome ETF
PBE
PBE
76 hedge funds and large institutions have $46.3M invested in Invesco Biotechnology & Genome ETF in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
59% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 29
Holders
76
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$258K | |
| 2 | +$155K | |
| 3 | +$84.1K | |
| 4 |
LPL Financial
San Diego,
California
|
+$63K |
| 5 |
JPMorgan Chase & Co
New York
|
+$28K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$745K | |
| 3 | -$611K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$550K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$268K |